Literature DB >> 26411523

PANCREATITIS OR NOT?--Elevated lipase and amylase in ICU patients.

Thiruvengadam Muniraj1, Saurabh Dang2, Capecomorin S Pitchumoni3.   

Abstract

Elevation in serum levels of pancreatic enzymes (Hyperamylasemia and/or Hyperlipasemia) can occur in any Intensive Care Unit (ICU) patient either as a result of true acute pancreatitis (AP) or as a reflection of a non-pancreatic disease. Although most patients may not have clinical pancreatitis, identifying true acute pancreatitis in the ICU setting may be critical in the presence of associated co-morbid conditions of the disease for which the patient is being managed. With neither amylase nor lipase being specific for pancreatitis, it is important for the clinician to be aware of different causes of hyperamylasemia and hyperlipasemia, especially when clinical diagnosis of pancreatitis is unclear. This review will focus on understanding different non-pancreatic conditions where there is elevation of pancreatitis enzymes and to identify true acute pancreatitis in critically ill patients without typical symptoms.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hyperlipasemia; ICU; Pancreatitis; hyperamylasemia

Mesh:

Substances:

Year:  2015        PMID: 26411523     DOI: 10.1016/j.jcrc.2015.08.020

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  20 in total

1.  Common and Emergent Oral and Gastrointestinal Manifestations of Eating Disorders.

Authors:  Jessica A Lin; Elizabeth R Woods; Elana M Bern
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-04

2.  Evaluation of Biochemical Markers Serum Amylase and Serum Lipase for the Assessment of Pancreatic Exocrine Function in Diabetes Mellitus.

Authors:  Mahesh Basavaraj Madole; Chandrashekhar M Iyer; Mamatha Thimmanna Madivalar; Satish Kishanrao Wadde; Deepak Sadashiv Howale
Journal:  J Clin Diagn Res       Date:  2016-11-01

3.  Predictive Factors for Intestinal Transmural Necrosis in Patients with Acute Mesenteric Ischemia.

Authors:  Sameh Hany Emile
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

4.  Effect of Best Practice Advisories on Sedation Protocol Compliance and Drug-Related Hazardous Condition Mitigation Among Critical Care Patients.

Authors:  Rebecca A Greene; Andrew R Zullo; Craig M Mailloux; Christine Berard-Collins; Mitchell M Levy; Timothy Amass
Journal:  Crit Care Med       Date:  2020-02       Impact factor: 7.598

5.  Predisposing Factors and Neurologic Outcomes of Patients with Elevated Serum Amylase and/or Lipase after Out-of-Hospital Cardiac Arrest: A Retrospective Cohort Study.

Authors:  Shin Young Park; Min Joung Kim; Incheol Park; Ha Yan Kim; Myeongjee Lee; Yoo Seok Park; Sung Phil Chung
Journal:  J Clin Med       Date:  2022-03-04       Impact factor: 4.241

6.  Sex differences impact the pancreatic response to chronic immobilization stress in rats.

Authors:  Sara Mohamed Naguib Abdel Hafez; Fatma Alzhraa Fouad Abdelbaky Allam; Eman Elbassuoni
Journal:  Cell Stress Chaperones       Date:  2020-09-28       Impact factor: 3.667

7.  The counteracting effects of (-)-Epigallocatechin-3-Gallate on the immobilization stress-induced adverse reactions in rat pancreas.

Authors:  Nermeen Mohammed Faheem; Tarek Mohamed Ali
Journal:  Cell Stress Chaperones       Date:  2020-10-01       Impact factor: 3.667

8.  Predictors of acute pancreatitis with low elevation of serum amylase.

Authors:  Wandong Hong; Wujun Geng; Bicheng Chen; Zarrin Basharat; Qingsong Wu; Vincent Zimmer; Mengtao Zhou
Journal:  Ther Clin Risk Manag       Date:  2017-12-14       Impact factor: 2.423

9.  Evaluation of Circulating MicroRNA Biomarkers in the Acute Pancreatic Injury Dog Model.

Authors:  Han-Byul Lee; Hyun-Kyu Park; Hyun-Ji Choi; Sora Lee; Sang-Joon Lee; Ji-Young Lee; Eun-Ho Cho; Hyo-Jeong Han; Ju-Hyung Seok; Woo-Chan Son
Journal:  Int J Mol Sci       Date:  2018-10-06       Impact factor: 5.923

10.  Marked Elevation of Lipase in COVID-19 Disease: A Cohort Study.

Authors:  Usman Barlass; Brett Wiliams; Klodian Dhana; Darbaz Adnan; Shahab R Khan; Mahboobeh Mahdavinia; Faraz Bishehsari
Journal:  Clin Transl Gastroenterol       Date:  2020-07       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.